Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
October 27, 2007
Impact of censoring data below an arbitrary quantification limit on structural model misspecification
Wonkyung Byon, Courtney V Fletcher, Richard C Brundage
Clinical Pharmacokinetics
|
May 16, 2019
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Wonkyung Byon, Samira Garonzik, Rebecca A Boyd, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 9, 2024
Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseases
Farzaneh Maleki, Elias Clark, Christopher Banfield, et al.
Clinical Pharmacology in Drug Development
|
July 24, 2024
Clinical Implications of Co-administering Apixaban with Key Interacting Medications
Nicholas Favatella, David Dalton, Wonkyung Byon, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 1, 2021
Population pharmacokinetics and exposure-response analyses of varenicline in adolescent smokers
Daryl J Fediuk, Kevin Sweeney, Vaishali Sahasrabudhe, et al.
Journal of Clinical Pharmacology
|
March 27, 2018
Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
Wonkyung Byon, Sunil Nepal, Alan E Schuster, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study
Samira Garonzik, Wonkyung Byon, Elsa Myers, et al.
Journal of Clinical Pharmacology
|
December 16, 2014
Randomized, blinded, placebo- and positive-controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval
Charles Frost, Sunil Nepal, Wonkyung Byon, et al.
Advances in Therapy
|
April 23, 2021
Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY
Alexander T Cohen, Sharon Pan, Wonkyung Byon, et al.
Journal of Clinical Pharmacology
|
April 2, 2010
Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change
Wonkyung Byon, Daniele Ouellet, Marci Chew, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Journal of Pharmacokinetics and Pharmacodynamics
|
October 27, 2007
Impact of censoring data below an arbitrary quantification limit on structural model misspecification
Wonkyung Byon, Courtney V Fletcher, Richard C Brundage
Clinical Pharmacokinetics
|
May 16, 2019
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Wonkyung Byon, Samira Garonzik, Rebecca A Boyd, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 9, 2024
Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseases
Farzaneh Maleki, Elias Clark, Christopher Banfield, et al.
Clinical Pharmacology in Drug Development
|
July 24, 2024
Clinical Implications of Co-administering Apixaban with Key Interacting Medications
Nicholas Favatella, David Dalton, Wonkyung Byon, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 1, 2021
Population pharmacokinetics and exposure-response analyses of varenicline in adolescent smokers
Daryl J Fediuk, Kevin Sweeney, Vaishali Sahasrabudhe, et al.
Journal of Clinical Pharmacology
|
March 27, 2018
Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
Wonkyung Byon, Sunil Nepal, Alan E Schuster, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study
Samira Garonzik, Wonkyung Byon, Elsa Myers, et al.
Journal of Clinical Pharmacology
|
December 16, 2014
Randomized, blinded, placebo- and positive-controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval
Charles Frost, Sunil Nepal, Wonkyung Byon, et al.
Advances in Therapy
|
April 23, 2021
Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY
Alexander T Cohen, Sharon Pan, Wonkyung Byon, et al.
Journal of Clinical Pharmacology
|
April 2, 2010
Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change
Wonkyung Byon, Daniele Ouellet, Marci Chew, et al.
Page
of 3